Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

SML3095

Sigma-Aldrich

SGC-BRDVIII-NC

≥98% (HPLC)

Synonym(s):

1,1-Dimethylethyl 4-[3-amino-6-(2-methoxyphenyl)-4-pyridazinyl]-1-piperazinecarboxylate, SGC-SMARCA-BRDVIII inactive control, SGC-SMARCA-BRDVIII negative control, tert-Butyl 4-[3-amino-6-(2-methoxyphenyl)pyridazin-4-yl]piperazine-1-carboxylate

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
MXP 2,567.00
25 MG
MXP 8,263.00

MXP 2,567.00

Estimated to ship onMay 28, 2025

Request a Bulk Order
All Photos(1)

Select a Size

Change View
5 MG
MXP 2,567.00
25 MG
MXP 8,263.00

About This Item

Empirical Formula (Hill Notation):
C20H27N5O3
CAS Number:
2650530-02-0
Molecular Weight:
385.46
UNSPSC Code:
12352200
NACRES:
NA.77

MXP 2,567.00

Estimated to ship onMay 28, 2025

Request a Bulk Order

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C(N1CCN(CC1)C2=C(N)N=NC(C3=CC=CC=C3OC)=C2)OC(C)(C)C

InChI

1S/C20H27N5O3/c1-20(2,3)28-19(26)25-11-9-24(10-12-25)16-13-15(22-23-18(16)21)14-7-5-6-8-17(14)27-4/h5-8,13H,9-12H2,1-4H3,(H2,21,23)

InChI key

YOBVMDSDYHOOLN-UHFFFAOYSA-N

Related Categories

Biochem/physiol Actions

Inactive analog of and the negative control for the SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor SGC-SMARCA-BRDVIII.
SGC-BRDVIII-NC is an inactive analog of and the recommended negative control for the potent, SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain (BRD) inhibitor SGC-SMARCA-BRDVIII.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000128885
0000128884
0000126810

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Marek Wanior et al.
Journal of medicinal chemistry, 63(23), 14680-14699 (2020-11-21)
Accessibility of the human genome is modulated by the ATP-driven SWI/SNF chromatin remodeling multiprotein complexes BAF (BRG1/BRM-associated factor) and PBAF (polybromo-associated BAF factor), which involves reading of acetylated histone tails by the bromodomain-containing proteins SMARCA2 (BRM), SMARCA4 (BRG1), and polybromo-1.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service